These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36530976)

  • 1. Simultaneous CSM-TACE with CalliSpheres
    Zhou J; Feng Z; Liu S; Li X; Liu Y; Gao F; Shen J; Zhang YW; Zhao GS; Zhang M
    Front Oncol; 2022; 12():998500. PubMed ID: 36530976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Transarterial Chemoembolization and Repeated Partial Splenic Embolization for Hepatocellular Carcinoma with Hypersplenism and Thrombocytopenia.
    Hong W; Wang Z; Yao W; Zhang X; Zhang L; Liang B
    J Hepatocell Carcinoma; 2024; 11():1065-1078. PubMed ID: 38882439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent partial splenic embolization with transcatheter arterial chemoembolization for hepatocellular carcinoma can maintain hepatic functional reserve.
    Ishikawa T; Kubota T; Horigome R; Kimura N; Honda H; Iwanaga A; Seki K; Honma T; Yoshida T
    Hepatol Res; 2014 Oct; 44(11):1056-61. PubMed ID: 23941627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of chemoembolization with CalliSpheres
    Liang B; Xiang H; Ma C; Xiong B; Ma Y; Zhao C; Yao Y; Zhang Z; Chen C; Li H; Long Q; Zhou J; Luo C; Qiu H; Hu H; Zhao H; Zhou G; Zheng C
    Cancer Manag Res; 2020; 12():941-956. PubMed ID: 32104076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Efficacy and Safety of Partial Splenic Embolization in Hepatocellular Carcinoma Patients with Thrombocytopenia Who Underwent Transarterial Chemoembolization.
    Kim NH; Kim HJ; Cho YK; Hong HP; Kim BI
    J Korean Med Sci; 2019 Aug; 34(30):e208. PubMed ID: 31373186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined treatment of hepatocellular carcinoma with partial splenic embolization and transcatheter hepatic arterial chemoembolization.
    Huang JH; Gao F; Gu YK; Li WQ; Lu LW
    World J Gastroenterol; 2007 Dec; 13(48):6593-7. PubMed ID: 18161933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of partial splenic embolization on transarterial chemoembolization for hepatocellular carcinoma with hypersplenism.
    Liu J; Wu Z; Zhang J; Xie Y; Sun P; Wu H; Chang X; Zhang L; Liu F
    Medicine (Baltimore); 2021 Jul; 100(26):e26441. PubMed ID: 34190168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial splenic embolization using polyvinyl alcohol particles for hypersplenism in cirrhosis: a prospective randomized study.
    Zhu K; Meng X; Li Z; Huang M; Guan S; Jiang Z; Shan H
    Eur J Radiol; 2008 Apr; 66(1):100-6. PubMed ID: 17532166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The significance of combined treatment for hepatocellular carcinoma with partial splenic embolization and transcatheter arterial chemoembolization using IA call/lipiodol].
    Harao M; Beppu T; Masuda T; Hayashi H; Okabe H; Okabe K; Imseung C; Komori H; Horino K; Baba H
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2027-9. PubMed ID: 19106512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative splenic embolization possible: application of 8Spheres conformal microspheres in partial splenic embolization (PSE).
    Lu H; Zheng C; Liang B; Xiong B
    BMC Gastroenterol; 2021 Oct; 21(1):407. PubMed ID: 34706678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Splenic embolization and hepatic chemoembolization: combined transcatheter treatment of hepatocellular carcinoma in cirrhosis with hypersplenism].
    Roversi R; Ricci S; Gambari PI; Castaldini L; Rossi G; Milandri G; Formica G; Dalmonte PR
    Radiol Med; 1993 Apr; 85(4):444-9. PubMed ID: 8390705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Response, Survival, and Safety of Transarterial Chemoembolization With CalliSpheres
    Liang B; Makamure J; Shu S; Zhang L; Sun T; Zheng C
    Front Oncol; 2021; 11():576232. PubMed ID: 33796448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on primary hepatocellular carcinoma associated with hypersplenism treated by partial splenic embolization combined with hepatic arterial chemoembolization].
    Huang JH; Wu PH; Gu YK; Zhang FJ; Li CX; Gao F; Zhang L; Fan WJ; Li CJ
    Ai Zheng; 2006 Aug; 25(8):1003-6. PubMed ID: 16965683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive predictive factors for CalliSpheres® microspheres (CSM) drug-eluting bead-transarterial chemoembolization and conventional transarterial chemoembolization on treatment response and survival in hepatocellular carcinoma patients.
    Chen C; Qiu H; Yao Y; Zhang Z; Ma C; Ma Y; Zhao C; Xiang H; Zhao H; Zheng C; Xiong B; Li H; Long Q; Zhou J; Luo C; Hu H
    Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101460. PubMed ID: 32593695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irinotecan eluting beads-transarterial chemoembolization using Callispheres® microspheres is an effective and safe approach in treating unresectable colorectal cancer liver metastases.
    Zhao G; Liu S; Zhang Y; Zhao T; Wang R; Bian J; Wu J; Zhou J
    Ir J Med Sci; 2022 Jun; 191(3):1139-1145. PubMed ID: 34264426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of heparin plus dexamethasone after partial splenic embolization for liver cirrhosis with massive splenomegaly.
    Lu H; Zheng C; Xiong B; Xia X
    BMC Gastroenterol; 2022 Nov; 22(1):470. PubMed ID: 36402985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial splenic embolization using Bletilla striata particles for hypersplenism in cirrhosis: a prospective study.
    Liu R; Teng XJ; He JF; Xiao SS; Yuan ZB; Li XJ; Gao XS; Zhou BM
    Am J Chin Med; 2011; 39(2):261-9. PubMed ID: 21476204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of treatment response, survival and safety between drug-eluting bead transarterial chemoembolization with CalliSpheres® microspheres versus conventional transarterial chemoembolization in treating hepatocellular carcinoma.
    Zhao C; Ma SPZCY
    J BUON; 2019; 24(3):1150-1166. PubMed ID: 31424674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the efficacy and safety of CalliSpheres® microsphere-transarterial chemoembolization in large hepatocellular carcinoma.
    Zhou C; Peng C; Liu F; Xiao J; Li G; Chen C; Shi L; Li H
    J Cancer Res Ther; 2023 Dec; 19(6):1575-1581. PubMed ID: 38156924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of drug-eluting bead transarterial chemoembolization with CalliSpheres® microsphere for hepatocellular carcinoma with portal vein tumor thrombus: a preliminary study.
    Zhou TY; Chen SQ; Wang HL; Weng SM; Zhou GH; Zhang YL; Nie CH; Zhu TY; Wang BQ; Yu ZN; Jing L; Chen F; Sun JH
    J Cancer; 2021; 12(15):4522-4529. PubMed ID: 34149916
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.